I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase I dose-escalation study to examine the safety and tol..:
Weiss, Glen J.
;
Donehower, Ross C.
;
Iyengar, Tara
...
Investigational New Drugs. 31 (2012) 1 - p. 136-144 , 2012
Link:
https://doi.org/10.1007/s10637-012-9815-9
RT Journal T1
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m2 every 21 days in patients with cancer
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s10637-012-9815-9&Exemplar=1&LAN=DE A1 Weiss, Glen J. A1 Donehower, Ross C. A1 Iyengar, Tara A1 Ramanathan, Ramesh K. A1 Lewandowski, Karen A1 Westin, Eric A1 Hurt, Karla A1 Hynes, Scott M. A1 Anthony, Stephen P. A1 McKane, Scott PB Springer Science and Business Media LLC YR 2012 SN 0167-6997 SN 1573-0646 JF Investigational New Drugs VO 31 IS 1 SP 136 OP 144 LK http://dx.doi.org/https://doi.org/10.1007/s10637-012-9815-9 DO https://doi.org/10.1007/s10637-012-9815-9 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)